NCT02035722View on ClinicalTrials.gov

Intravitreal Injections-related Anxiety

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Age-related Macular Degeneration
Interventions
BEHAVIORAL

Printed materials

AMD-related information is presented to patients in the form of a brochure (i.e. printed materials)

BEHAVIORAL

Video

AMD-related information is presented as in the form of a video

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02035722 - Intravitreal Injections-related Anxiety | Biotech Hunter | Biotech Hunter